| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Curis, Inc. (C.V.P., C.C.D., J.L.Z.), Oncology Group, Cambridge, Massachusetts 02163; Division of Urology/Department of Surgery (J.G., A.S., A.M., R.Li., W.B.), University of Wisconsin, Madison, Wisconsin 53792; and Division of Urology (J.B.T.), University of Kansas Medical Center, Kansas City, Kansas 66113; and Northwestern University Feinberg School of Medicine (L.F., W.C., R.La., M.L.G.L.), Chicago, Illinois 60611
Address all correspondence and requests for reprints to: Wade Bushman, Division of Urology/Department of Surgery, University of Wisconsin, G5/350 Clinical Sciences Center, 600 Highland Avenue, Madison, Wisconsin. E-mail: bushman{at}surgery.wisc.edu.
During fetal prostate development, Sonic hedgehog (Shh) expression by the urogenital sinus epithelium activates Gli-1 expression in the adjacent mesenchyme and promotes outgrowth of the nascent ducts. Shh signaling is down-regulated at the conclusion of prostate ductal development. However, a survey of adult human prostate tissues reveals substantial levels of Shh signaling in normal, hyperplasic, and malignant prostate tissue. In cancer specimens, the Shh expression is localized to the tumor epithelium, whereas Gli-1 expression is localized to the tumor stroma. Tight correlation between the levels of Shh and Gli-1 expression suggests active signaling between the tissue layers. To determine whether Shh-Gli-1 signaling could be functionally important for tumor growth and progression, we performed experiments with the LNCaP xenograft tumor model and demonstrated that: 1) Shh expressed by LNCaP tumor cells activates Gli-1 expression in the tumor stroma, 2) genetically engineered Shh overexpression in LNCaP cells leads to increased tumor stromal Gli-1 expression, and 3) Shh overexpression dramatically accelerates tumor growth. These data suggest that hedgehog signaling from prostate cancer cells to the stroma can elicit the expression of paracrine signals, which promote tumor growth.
This article has been cited by other articles:
![]() |
M. Bifulco, A. M. Malfitano, S. Pisanti, and C. Laezza Endocannabinoids in endocrine and related tumours Endocr. Relat. Cancer, June 1, 2008; 15(2): 391 - 408. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mimeault, P. P. Mehta, R. Hauke, and S. K. Batra Functions of Normal and Malignant Prostatic Stem/Progenitor Cells in Tissue Regeneration and Cancer Progression and Novel Targeting Therapies Endocr. Rev., April 1, 2008; 29(2): 234 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liu, C. Ginestier, E. Charafe-Jauffret, H. Foco, C. G. Kleer, S. D. Merajver, G. Dontu, and M. S. Wicha BRCA1 regulates human mammary stem/progenitor cell fate PNAS, February 5, 2008; 105(5): 1680 - 1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. de Sauvage and J. C. Marsters Jr. The Hedgehog Signaling Pathway in Cancer ASCO Educational Book, January 1, 2008; 2008(1): e1 - e4. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Thiyagarajan, N. Bhatia, S. Reagan-Shaw, D. Cozma, A. Thomas-Tikhonenko, N. Ahmad, and V. S. Spiegelman Role of GLI2 Transcription Factor in Growth and Tumorigenicity of Prostate Cells Cancer Res., November 15, 2007; 67(22): 10642 - 10646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lauth, A. Bergstrom, T. Shimokawa, and R. Toftgard Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists PNAS, May 15, 2007; 104(20): 8455 - 8460. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kim, J. W. Yoon, X. Xiao, N. M. Dean, B. P. Monia, and E. G. Marcusson Selective Down-Regulation of Glioma-Associated Oncogene 2 Inhibits the Proliferation of Hepatocellular Carcinoma Cells Cancer Res., April 15, 2007; 67(8): 3583 - 3593. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mimeault, S. L. Johansson, G. Vankatraman, E. Moore, J.-P. Henichart, P. Depreux, M.-F. Lin, and S. K. Batra Combined targeting of epidermal growth factor receptor and hedgehog signaling by gefitinib and cyclopamine cooperatively improves the cytotoxic effects of docetaxel on metastatic prostate cancer cells Mol. Cancer Ther., March 1, 2007; 6(3): 967 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. W. Tam, A. S. Cheng, R. Y. M. Ma, K.-M. Yao, and S. Y. W. Shiu Inhibition of Prostate Cancer Cell Growth by Human Secreted PDZ Domain-Containing Protein 2, a Potential Autocrine Prostate Tumor Suppressor Endocrinology, November 1, 2006; 147(11): 5023 - 5033. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sims-Mourtada, J. G. Izzo, S. Apisarnthanarax, T.-T. Wu, U. Malhotra, R. Luthra, Z. Liao, R. Komaki, A. van der Kogel, J. Ajani, et al. Hedgehog: an Attribute to Tumor Regrowth after Chemoradiotherapy and a Target to Improve Radiation Response. Clin. Cancer Res., November 1, 2006; 12(21): 6565 - 6572. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakashima, M. Nakamura, H. Yamaguchi, N. Yamanaka, T. Akiyoshi, K. Koga, K. Yamaguchi, M. Tsuneyoshi, M. Tanaka, and M. Katano Nuclear Factor-{kappa}B Contributes to Hedgehog Signaling Pathway Activation through Sonic Hedgehog Induction in Pancreatic Cancer. Cancer Res., July 15, 2006; 66(14): 7041 - 7049. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bhatia, S. Thiyagarajan, I. Elcheva, M. Saleem, A. Dlugosz, H. Mukhtar, and V. S. Spiegelman Gli2 Is Targeted for Ubiquitination and Degradation by beta-TrCP Ubiquitin Ligase J. Biol. Chem., July 14, 2006; 281(28): 19320 - 19326. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Huang, J. He, X. Zhang, Y. Bian, L. Yang, G. Xie, K. Zhang, W. Tang, A. A. Stelter, Q. Wang, et al. Activation of the hedgehog pathway in human hepatocellular carcinomas Carcinogenesis, July 1, 2006; 27(7): 1334 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Sicklick, Y.-X. Li, A. Jayaraman, R. Kannangai, Y. Qi, P. Vivekanandan, J. W. Ludlow, K. Owzar, W. Chen, M. S. Torbenson, et al. Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis Carcinogenesis, April 1, 2006; 27(4): 748 - 757. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mimeault and S. K. Batra Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies Carcinogenesis, January 1, 2006; 27(1): 1 - 22. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Ma, K. Chen, S. Huang, X. Zhang, P. A. Adegboyega, B.M. Evers, H. Zhang, and J. Xie Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas Carcinogenesis, October 1, 2005; 26(10): 1698 - 1705. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Gao, K. Ishii, J. Mirosevich, S. Kuwajima, S. R. Oppenheimer, R. L. Roberts, M. Jiang, X. Yu, S. B. Shappell, R. M. Caprioli, et al. Forkhead box A1 regulates prostate ductal morphogenesis and promotes epithelial cell maturation Development, August 1, 2005; 132(15): 3431 - 3443. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sanchez, V. Clement, and A. Ruiz i Altaba Therapeutic Targeting of the Hedgehog-GLI Pathway in Prostate Cancer Cancer Res., April 15, 2005; 65(8): 2990 - 2992. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |